Last reviewed · How we verify
Tang
Tang is a medication used to treat type 2 diabetes by lowering blood sugar levels.
Tang is a medication used to treat type 2 diabetes by lowering blood sugar levels. Used for Type 2 diabetes.
At a glance
| Generic name | Tang |
|---|---|
| Sponsor | Louisville Metabolic and Atherosclerosis Research Center |
| Drug class | DPP-4 inhibitor |
| Target | DPP-4 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | FDA-approved |
Mechanism of action
Tang works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which breaks down incretin hormones. This leads to increased levels of incretin hormones, which in turn stimulate the release of insulin and decrease the release of glucagon, resulting in lower blood sugar levels.
Approved indications
- Type 2 diabetes
Common side effects
- Headache
- Nausea
- Diarrhea
- Fatigue
- Muscle pain
Key clinical trials
- Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
- Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy (NA)
- A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension (PHASE2, PHASE3)
- Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway (NA)
- Hormonal Regulation of Cardiometabolic Health Study
- A Clinical Trial to Determine the Safety and Efficacy of an Origin Satiety Complex on Self-reported Hunger and Satiety in Healthy Adults (NA)
- Effects of Acupuncture on Perceived Stress and Health in Military Service Members (NA)
- A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tang CI brief — competitive landscape report
- Tang updates RSS · CI watch RSS
- Louisville Metabolic and Atherosclerosis Research Center portfolio CI